Review




Structured Review

Procell Inc human lo2 hepatocytes
Protective efficacy of AVI against cisplatin‐induced cytotoxicity and apoptosis in <t>LO2</t> cells. (A) Indicates that LO2 cell viability was not affected by AVI intervention at concentrations ranging from 0 to 400 μM over a period of 2 days. (B) Indicates a significant difference in LO2 cell viability following cisplatin treatment with vs. without AVI co‐culture. (C) Illustrates the dose‐response curves of cell viability to cisplatin following different pretreatment durations (0, 6, 12, and 24 h) with AVI. (D) Shows the apoptosis rate in LO2 cells was quantified using Annexin V‐FITC double staining, (E) shows Cis group has the highest rate of cell apoptosis, while co‐culture with AVI significantly reduced the overall cell apoptosis rate caused by Cis. (F) Shows the apoptosis of cells in each group. Apoptosis was significantly observed in the Cis group, while AVI co‐culture could significantly improve apoptosis. (G) Shows the total amount of ROS produced by cells in each group. The Cis group significantly increased ROS, while AVI co‐culture could significantly reduce the generation of ROS within cells. ( n = 3, * p < 0.05, ** p < 0.01,*** p < 0.001).
Human Lo2 Hepatocytes, supplied by Procell Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human lo2 hepatocytes/product/Procell Inc
Average 86 stars, based on 1 article reviews
human lo2 hepatocytes - by Bioz Stars, 2026-06
86/100 stars

Images

1) Product Images from "Asperosaponin VI Alleviates Cisplatin‐Induced Liver Injury Through the Nrf2/HO‐1 Signaling Pathway"

Article Title: Asperosaponin VI Alleviates Cisplatin‐Induced Liver Injury Through the Nrf2/HO‐1 Signaling Pathway

Journal: Immunity, Inflammation and Disease

doi: 10.1002/iid3.70454

Protective efficacy of AVI against cisplatin‐induced cytotoxicity and apoptosis in LO2 cells. (A) Indicates that LO2 cell viability was not affected by AVI intervention at concentrations ranging from 0 to 400 μM over a period of 2 days. (B) Indicates a significant difference in LO2 cell viability following cisplatin treatment with vs. without AVI co‐culture. (C) Illustrates the dose‐response curves of cell viability to cisplatin following different pretreatment durations (0, 6, 12, and 24 h) with AVI. (D) Shows the apoptosis rate in LO2 cells was quantified using Annexin V‐FITC double staining, (E) shows Cis group has the highest rate of cell apoptosis, while co‐culture with AVI significantly reduced the overall cell apoptosis rate caused by Cis. (F) Shows the apoptosis of cells in each group. Apoptosis was significantly observed in the Cis group, while AVI co‐culture could significantly improve apoptosis. (G) Shows the total amount of ROS produced by cells in each group. The Cis group significantly increased ROS, while AVI co‐culture could significantly reduce the generation of ROS within cells. ( n = 3, * p < 0.05, ** p < 0.01,*** p < 0.001).
Figure Legend Snippet: Protective efficacy of AVI against cisplatin‐induced cytotoxicity and apoptosis in LO2 cells. (A) Indicates that LO2 cell viability was not affected by AVI intervention at concentrations ranging from 0 to 400 μM over a period of 2 days. (B) Indicates a significant difference in LO2 cell viability following cisplatin treatment with vs. without AVI co‐culture. (C) Illustrates the dose‐response curves of cell viability to cisplatin following different pretreatment durations (0, 6, 12, and 24 h) with AVI. (D) Shows the apoptosis rate in LO2 cells was quantified using Annexin V‐FITC double staining, (E) shows Cis group has the highest rate of cell apoptosis, while co‐culture with AVI significantly reduced the overall cell apoptosis rate caused by Cis. (F) Shows the apoptosis of cells in each group. Apoptosis was significantly observed in the Cis group, while AVI co‐culture could significantly improve apoptosis. (G) Shows the total amount of ROS produced by cells in each group. The Cis group significantly increased ROS, while AVI co‐culture could significantly reduce the generation of ROS within cells. ( n = 3, * p < 0.05, ** p < 0.01,*** p < 0.001).

Techniques Used: Co-Culture Assay, Double Staining, Produced

Transcriptome sequencing results from four experimental groups of LO2 cells. (A) Principal component analysis (PCA) shows clear separation along PC1 among different treatment groups, indicating value for further analysis. (B) Gene expression distribution (violin plot) demonstrates consistency in expression levels across samples. (C) Heatmap of differentially expressed gene clustering, and (D) Volcano plot of differentially expressed genes, both reveal significant differential gene expression between the Cis group and the AVI+Cis group. (E) Gene Ontology (GO) enrichment analysis shows that the gene set is significantly enriched in the three categories: biological process, molecular function, and cellular component. (F) Based on KEGG pathway enrichment analysis results, the gene set primarily covers key physiological and pathological processes such as immune defense, apoptosis, and signal transduction. (G) Results of Gene Set Enrichment Analysis (GSEA) show that gene sets involved in oxidative stress, inflammatory response, and programmed cell death are significantly negatively enriched in AVI+Cis group.
Figure Legend Snippet: Transcriptome sequencing results from four experimental groups of LO2 cells. (A) Principal component analysis (PCA) shows clear separation along PC1 among different treatment groups, indicating value for further analysis. (B) Gene expression distribution (violin plot) demonstrates consistency in expression levels across samples. (C) Heatmap of differentially expressed gene clustering, and (D) Volcano plot of differentially expressed genes, both reveal significant differential gene expression between the Cis group and the AVI+Cis group. (E) Gene Ontology (GO) enrichment analysis shows that the gene set is significantly enriched in the three categories: biological process, molecular function, and cellular component. (F) Based on KEGG pathway enrichment analysis results, the gene set primarily covers key physiological and pathological processes such as immune defense, apoptosis, and signal transduction. (G) Results of Gene Set Enrichment Analysis (GSEA) show that gene sets involved in oxidative stress, inflammatory response, and programmed cell death are significantly negatively enriched in AVI+Cis group.

Techniques Used: Sequencing, Gene Expression, Expressing, Transduction

AVI suppresses hepatocyte inflammation and apoptosis in LO2 cells via activation of the Nrf2/HO‐1 axis. Total protein was extracted from the LO2cell from the control, Cis, and AVI+Cis, Bru+AVI+Cis, Vitc+Cis groups. (A–C) Representative images of western blots depicting the levels of Nrf2 and HO‐1 in the LO2 cell, and the protein/GAPDH ratios determined by densitometric analysis of the western blots. (D–H) Representative images of western blots depicting the levels of Caspase‐1, NF‐κB, NLRP3 and Caspase‐3 in the LO2 cell, and the protein/GAPDH ratios determined by densitometric analysis of the western blots.
Figure Legend Snippet: AVI suppresses hepatocyte inflammation and apoptosis in LO2 cells via activation of the Nrf2/HO‐1 axis. Total protein was extracted from the LO2cell from the control, Cis, and AVI+Cis, Bru+AVI+Cis, Vitc+Cis groups. (A–C) Representative images of western blots depicting the levels of Nrf2 and HO‐1 in the LO2 cell, and the protein/GAPDH ratios determined by densitometric analysis of the western blots. (D–H) Representative images of western blots depicting the levels of Caspase‐1, NF‐κB, NLRP3 and Caspase‐3 in the LO2 cell, and the protein/GAPDH ratios determined by densitometric analysis of the western blots.

Techniques Used: Activation Assay, Control, Western Blot



Similar Products

94
ATCC human normal hepatocytes lo2
Human Normal Hepatocytes Lo2, supplied by ATCC, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human normal hepatocytes lo2/product/ATCC
Average 94 stars, based on 1 article reviews
human normal hepatocytes lo2 - by Bioz Stars, 2026-06
94/100 stars
  Buy from Supplier

86
Procell Inc human lo2 hepatocytes
Protective efficacy of AVI against cisplatin‐induced cytotoxicity and apoptosis in <t>LO2</t> cells. (A) Indicates that LO2 cell viability was not affected by AVI intervention at concentrations ranging from 0 to 400 μM over a period of 2 days. (B) Indicates a significant difference in LO2 cell viability following cisplatin treatment with vs. without AVI co‐culture. (C) Illustrates the dose‐response curves of cell viability to cisplatin following different pretreatment durations (0, 6, 12, and 24 h) with AVI. (D) Shows the apoptosis rate in LO2 cells was quantified using Annexin V‐FITC double staining, (E) shows Cis group has the highest rate of cell apoptosis, while co‐culture with AVI significantly reduced the overall cell apoptosis rate caused by Cis. (F) Shows the apoptosis of cells in each group. Apoptosis was significantly observed in the Cis group, while AVI co‐culture could significantly improve apoptosis. (G) Shows the total amount of ROS produced by cells in each group. The Cis group significantly increased ROS, while AVI co‐culture could significantly reduce the generation of ROS within cells. ( n = 3, * p < 0.05, ** p < 0.01,*** p < 0.001).
Human Lo2 Hepatocytes, supplied by Procell Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human lo2 hepatocytes/product/Procell Inc
Average 86 stars, based on 1 article reviews
human lo2 hepatocytes - by Bioz Stars, 2026-06
86/100 stars
  Buy from Supplier

86
Keygen Biotech lo2 human hepatocyte cell lines
Protective efficacy of AVI against cisplatin‐induced cytotoxicity and apoptosis in <t>LO2</t> cells. (A) Indicates that LO2 cell viability was not affected by AVI intervention at concentrations ranging from 0 to 400 μM over a period of 2 days. (B) Indicates a significant difference in LO2 cell viability following cisplatin treatment with vs. without AVI co‐culture. (C) Illustrates the dose‐response curves of cell viability to cisplatin following different pretreatment durations (0, 6, 12, and 24 h) with AVI. (D) Shows the apoptosis rate in LO2 cells was quantified using Annexin V‐FITC double staining, (E) shows Cis group has the highest rate of cell apoptosis, while co‐culture with AVI significantly reduced the overall cell apoptosis rate caused by Cis. (F) Shows the apoptosis of cells in each group. Apoptosis was significantly observed in the Cis group, while AVI co‐culture could significantly improve apoptosis. (G) Shows the total amount of ROS produced by cells in each group. The Cis group significantly increased ROS, while AVI co‐culture could significantly reduce the generation of ROS within cells. ( n = 3, * p < 0.05, ** p < 0.01,*** p < 0.001).
Lo2 Human Hepatocyte Cell Lines, supplied by Keygen Biotech, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/lo2 human hepatocyte cell lines/product/Keygen Biotech
Average 86 stars, based on 1 article reviews
lo2 human hepatocyte cell lines - by Bioz Stars, 2026-06
86/100 stars
  Buy from Supplier

86
Servicebio Inc lo2 human hepatocytes
Protective efficacy of AVI against cisplatin‐induced cytotoxicity and apoptosis in <t>LO2</t> cells. (A) Indicates that LO2 cell viability was not affected by AVI intervention at concentrations ranging from 0 to 400 μM over a period of 2 days. (B) Indicates a significant difference in LO2 cell viability following cisplatin treatment with vs. without AVI co‐culture. (C) Illustrates the dose‐response curves of cell viability to cisplatin following different pretreatment durations (0, 6, 12, and 24 h) with AVI. (D) Shows the apoptosis rate in LO2 cells was quantified using Annexin V‐FITC double staining, (E) shows Cis group has the highest rate of cell apoptosis, while co‐culture with AVI significantly reduced the overall cell apoptosis rate caused by Cis. (F) Shows the apoptosis of cells in each group. Apoptosis was significantly observed in the Cis group, while AVI co‐culture could significantly improve apoptosis. (G) Shows the total amount of ROS produced by cells in each group. The Cis group significantly increased ROS, while AVI co‐culture could significantly reduce the generation of ROS within cells. ( n = 3, * p < 0.05, ** p < 0.01,*** p < 0.001).
Lo2 Human Hepatocytes, supplied by Servicebio Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/lo2 human hepatocytes/product/Servicebio Inc
Average 86 stars, based on 1 article reviews
lo2 human hepatocytes - by Bioz Stars, 2026-06
86/100 stars
  Buy from Supplier

90
Nanjing KeyGen Biotech Co Ltd human lo2 normal hepatocyte
Protective efficacy of AVI against cisplatin‐induced cytotoxicity and apoptosis in <t>LO2</t> cells. (A) Indicates that LO2 cell viability was not affected by AVI intervention at concentrations ranging from 0 to 400 μM over a period of 2 days. (B) Indicates a significant difference in LO2 cell viability following cisplatin treatment with vs. without AVI co‐culture. (C) Illustrates the dose‐response curves of cell viability to cisplatin following different pretreatment durations (0, 6, 12, and 24 h) with AVI. (D) Shows the apoptosis rate in LO2 cells was quantified using Annexin V‐FITC double staining, (E) shows Cis group has the highest rate of cell apoptosis, while co‐culture with AVI significantly reduced the overall cell apoptosis rate caused by Cis. (F) Shows the apoptosis of cells in each group. Apoptosis was significantly observed in the Cis group, while AVI co‐culture could significantly improve apoptosis. (G) Shows the total amount of ROS produced by cells in each group. The Cis group significantly increased ROS, while AVI co‐culture could significantly reduce the generation of ROS within cells. ( n = 3, * p < 0.05, ** p < 0.01,*** p < 0.001).
Human Lo2 Normal Hepatocyte, supplied by Nanjing KeyGen Biotech Co Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human lo2 normal hepatocyte/product/Nanjing KeyGen Biotech Co Ltd
Average 90 stars, based on 1 article reviews
human lo2 normal hepatocyte - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

90
Keygen Biotech lo2 (human normal hepatocytes)
Protective efficacy of AVI against cisplatin‐induced cytotoxicity and apoptosis in <t>LO2</t> cells. (A) Indicates that LO2 cell viability was not affected by AVI intervention at concentrations ranging from 0 to 400 μM over a period of 2 days. (B) Indicates a significant difference in LO2 cell viability following cisplatin treatment with vs. without AVI co‐culture. (C) Illustrates the dose‐response curves of cell viability to cisplatin following different pretreatment durations (0, 6, 12, and 24 h) with AVI. (D) Shows the apoptosis rate in LO2 cells was quantified using Annexin V‐FITC double staining, (E) shows Cis group has the highest rate of cell apoptosis, while co‐culture with AVI significantly reduced the overall cell apoptosis rate caused by Cis. (F) Shows the apoptosis of cells in each group. Apoptosis was significantly observed in the Cis group, while AVI co‐culture could significantly improve apoptosis. (G) Shows the total amount of ROS produced by cells in each group. The Cis group significantly increased ROS, while AVI co‐culture could significantly reduce the generation of ROS within cells. ( n = 3, * p < 0.05, ** p < 0.01,*** p < 0.001).
Lo2 (Human Normal Hepatocytes), supplied by Keygen Biotech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/lo2 (human normal hepatocytes)/product/Keygen Biotech
Average 90 stars, based on 1 article reviews
lo2 (human normal hepatocytes) - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

90
iCell Bioscience Inc human fetal hepatocyte cell line lo2
Protective efficacy of AVI against cisplatin‐induced cytotoxicity and apoptosis in <t>LO2</t> cells. (A) Indicates that LO2 cell viability was not affected by AVI intervention at concentrations ranging from 0 to 400 μM over a period of 2 days. (B) Indicates a significant difference in LO2 cell viability following cisplatin treatment with vs. without AVI co‐culture. (C) Illustrates the dose‐response curves of cell viability to cisplatin following different pretreatment durations (0, 6, 12, and 24 h) with AVI. (D) Shows the apoptosis rate in LO2 cells was quantified using Annexin V‐FITC double staining, (E) shows Cis group has the highest rate of cell apoptosis, while co‐culture with AVI significantly reduced the overall cell apoptosis rate caused by Cis. (F) Shows the apoptosis of cells in each group. Apoptosis was significantly observed in the Cis group, while AVI co‐culture could significantly improve apoptosis. (G) Shows the total amount of ROS produced by cells in each group. The Cis group significantly increased ROS, while AVI co‐culture could significantly reduce the generation of ROS within cells. ( n = 3, * p < 0.05, ** p < 0.01,*** p < 0.001).
Human Fetal Hepatocyte Cell Line Lo2, supplied by iCell Bioscience Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human fetal hepatocyte cell line lo2/product/iCell Bioscience Inc
Average 90 stars, based on 1 article reviews
human fetal hepatocyte cell line lo2 - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

90
Servicebio Inc human normal hepatocyte cell line lo2
Analysis of the expression of POC1A in various classifications of HCC patients, as well as in HCC and liver cancer cell lines. (A) Comparison of POC1A between cancer tissue samples and normal tissue samples. (B) Comparison of the expression of POC1A in different genders. (C) Comparison of the expression of POC1A in different age groups. (D) The expression levels of POC1A were all higher in the Caucasian, African-American, and Asian HCC patients than the normal patients. The expression of POC1A was significantly higher in LIHC tissue samples from Asian patients than LIHC tissue samples from Caucasian patients. (E) The expression of POC1A in individual cancer stages. (F) The expression of POC1A in different transistor grades. (G) The expression of POC1A in tumor (T) stage. (H) The expression of POC1A in node (N) stage. (I) The expression of POC1A in metastasis (M) stage. (J) Analysis of POC1A expression in normal liver tissue and cancer tissue samples from patients with hepatocellular carcinoma using immunohistochemical methods in the Human Protein Atlas database. Liver sample: https://www.proteinatlas.org/ENSG00000164087-POC1A/tissue/liver#img , hepatocellular samples: https://www.proteinatlas.org/ENSG00000164087-POC1A/pathology/liver+cancer#img . Scale bar: 100 µm. (K) Analysis of POC1A mRNA expression in <t>LO2</t> and HepG2 cell lines by qPCR assay. *, P<0.05; **, P<0.01; -: no significance. TCGA, The Cancer Genome Atlas; HCC, hepatocellular carcinoma; LIHC, liver hepatocellular carcinoma; mRNA, messenger RNA; qPCR, quantitative polymerase chain reaction; POC1A , POC1 centriolar protein A.
Human Normal Hepatocyte Cell Line Lo2, supplied by Servicebio Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human normal hepatocyte cell line lo2/product/Servicebio Inc
Average 90 stars, based on 1 article reviews
human normal hepatocyte cell line lo2 - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

90
China Center for Type Culture Collection human hepatocyte lo2 cells
Ferroptosis inhibitor attenuated ferroptosis-related death in <t>LO2</t> cells under PA treatment. (a) Representative Oil Red O staining of the LO2 cells cultured in 300 μ M PA for 24 h; scale bar: 100 μ m. (b) The quantitative analysis of Oil Red O–stained cells. (c) The viability of LO2 cells treated with PA or PA and Fer-1 was assessed. The cells were treated with PA (300 μ M) or PA (300 μ M) and Fer-1 (60 μ M) for 24 h, and then the viability of cells in each group was measured by the CCK-8 assay. (d) The level of the LDH released in LO2 cells treated with PA or PA and Fer-1 was measured using the LDH cytotoxicity assay kit. (e, f) The LO2 cells were stained with the LPO-specific dye BODIPY 581/591 C11, and LPO was detected by flow cytometry after the LO2 cells were treated with PA or PA and Fer-1. (g, h) LO2 cells were treated with PA or PA and Fer-1, stained with Annexin V-FITC and PI, and then cells that underwent apoptosis were quantified by flow cytometry; ⁣ ∗ p < 0.05, ⁣ ∗∗ p < 0.01, and ⁣ ∗∗∗ p < 0.001 between the indicated groups.
Human Hepatocyte Lo2 Cells, supplied by China Center for Type Culture Collection, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human hepatocyte lo2 cells/product/China Center for Type Culture Collection
Average 90 stars, based on 1 article reviews
human hepatocyte lo2 cells - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

Image Search Results


Protective efficacy of AVI against cisplatin‐induced cytotoxicity and apoptosis in LO2 cells. (A) Indicates that LO2 cell viability was not affected by AVI intervention at concentrations ranging from 0 to 400 μM over a period of 2 days. (B) Indicates a significant difference in LO2 cell viability following cisplatin treatment with vs. without AVI co‐culture. (C) Illustrates the dose‐response curves of cell viability to cisplatin following different pretreatment durations (0, 6, 12, and 24 h) with AVI. (D) Shows the apoptosis rate in LO2 cells was quantified using Annexin V‐FITC double staining, (E) shows Cis group has the highest rate of cell apoptosis, while co‐culture with AVI significantly reduced the overall cell apoptosis rate caused by Cis. (F) Shows the apoptosis of cells in each group. Apoptosis was significantly observed in the Cis group, while AVI co‐culture could significantly improve apoptosis. (G) Shows the total amount of ROS produced by cells in each group. The Cis group significantly increased ROS, while AVI co‐culture could significantly reduce the generation of ROS within cells. ( n = 3, * p < 0.05, ** p < 0.01,*** p < 0.001).

Journal: Immunity, Inflammation and Disease

Article Title: Asperosaponin VI Alleviates Cisplatin‐Induced Liver Injury Through the Nrf2/HO‐1 Signaling Pathway

doi: 10.1002/iid3.70454

Figure Lengend Snippet: Protective efficacy of AVI against cisplatin‐induced cytotoxicity and apoptosis in LO2 cells. (A) Indicates that LO2 cell viability was not affected by AVI intervention at concentrations ranging from 0 to 400 μM over a period of 2 days. (B) Indicates a significant difference in LO2 cell viability following cisplatin treatment with vs. without AVI co‐culture. (C) Illustrates the dose‐response curves of cell viability to cisplatin following different pretreatment durations (0, 6, 12, and 24 h) with AVI. (D) Shows the apoptosis rate in LO2 cells was quantified using Annexin V‐FITC double staining, (E) shows Cis group has the highest rate of cell apoptosis, while co‐culture with AVI significantly reduced the overall cell apoptosis rate caused by Cis. (F) Shows the apoptosis of cells in each group. Apoptosis was significantly observed in the Cis group, while AVI co‐culture could significantly improve apoptosis. (G) Shows the total amount of ROS produced by cells in each group. The Cis group significantly increased ROS, while AVI co‐culture could significantly reduce the generation of ROS within cells. ( n = 3, * p < 0.05, ** p < 0.01,*** p < 0.001).

Article Snippet: Human LO2 hepatocytes (Procell Biotechnology, China; catalog CM‐0111) were cultured in complete growth medium supplemented with 10% fetal bovine serum (FBS; Biosharp, China, catalog BL201A) and 1% penicillin‐streptomycin (Biosharp, China, catalogBL505A).

Techniques: Co-Culture Assay, Double Staining, Produced

Transcriptome sequencing results from four experimental groups of LO2 cells. (A) Principal component analysis (PCA) shows clear separation along PC1 among different treatment groups, indicating value for further analysis. (B) Gene expression distribution (violin plot) demonstrates consistency in expression levels across samples. (C) Heatmap of differentially expressed gene clustering, and (D) Volcano plot of differentially expressed genes, both reveal significant differential gene expression between the Cis group and the AVI+Cis group. (E) Gene Ontology (GO) enrichment analysis shows that the gene set is significantly enriched in the three categories: biological process, molecular function, and cellular component. (F) Based on KEGG pathway enrichment analysis results, the gene set primarily covers key physiological and pathological processes such as immune defense, apoptosis, and signal transduction. (G) Results of Gene Set Enrichment Analysis (GSEA) show that gene sets involved in oxidative stress, inflammatory response, and programmed cell death are significantly negatively enriched in AVI+Cis group.

Journal: Immunity, Inflammation and Disease

Article Title: Asperosaponin VI Alleviates Cisplatin‐Induced Liver Injury Through the Nrf2/HO‐1 Signaling Pathway

doi: 10.1002/iid3.70454

Figure Lengend Snippet: Transcriptome sequencing results from four experimental groups of LO2 cells. (A) Principal component analysis (PCA) shows clear separation along PC1 among different treatment groups, indicating value for further analysis. (B) Gene expression distribution (violin plot) demonstrates consistency in expression levels across samples. (C) Heatmap of differentially expressed gene clustering, and (D) Volcano plot of differentially expressed genes, both reveal significant differential gene expression between the Cis group and the AVI+Cis group. (E) Gene Ontology (GO) enrichment analysis shows that the gene set is significantly enriched in the three categories: biological process, molecular function, and cellular component. (F) Based on KEGG pathway enrichment analysis results, the gene set primarily covers key physiological and pathological processes such as immune defense, apoptosis, and signal transduction. (G) Results of Gene Set Enrichment Analysis (GSEA) show that gene sets involved in oxidative stress, inflammatory response, and programmed cell death are significantly negatively enriched in AVI+Cis group.

Article Snippet: Human LO2 hepatocytes (Procell Biotechnology, China; catalog CM‐0111) were cultured in complete growth medium supplemented with 10% fetal bovine serum (FBS; Biosharp, China, catalog BL201A) and 1% penicillin‐streptomycin (Biosharp, China, catalogBL505A).

Techniques: Sequencing, Gene Expression, Expressing, Transduction

AVI suppresses hepatocyte inflammation and apoptosis in LO2 cells via activation of the Nrf2/HO‐1 axis. Total protein was extracted from the LO2cell from the control, Cis, and AVI+Cis, Bru+AVI+Cis, Vitc+Cis groups. (A–C) Representative images of western blots depicting the levels of Nrf2 and HO‐1 in the LO2 cell, and the protein/GAPDH ratios determined by densitometric analysis of the western blots. (D–H) Representative images of western blots depicting the levels of Caspase‐1, NF‐κB, NLRP3 and Caspase‐3 in the LO2 cell, and the protein/GAPDH ratios determined by densitometric analysis of the western blots.

Journal: Immunity, Inflammation and Disease

Article Title: Asperosaponin VI Alleviates Cisplatin‐Induced Liver Injury Through the Nrf2/HO‐1 Signaling Pathway

doi: 10.1002/iid3.70454

Figure Lengend Snippet: AVI suppresses hepatocyte inflammation and apoptosis in LO2 cells via activation of the Nrf2/HO‐1 axis. Total protein was extracted from the LO2cell from the control, Cis, and AVI+Cis, Bru+AVI+Cis, Vitc+Cis groups. (A–C) Representative images of western blots depicting the levels of Nrf2 and HO‐1 in the LO2 cell, and the protein/GAPDH ratios determined by densitometric analysis of the western blots. (D–H) Representative images of western blots depicting the levels of Caspase‐1, NF‐κB, NLRP3 and Caspase‐3 in the LO2 cell, and the protein/GAPDH ratios determined by densitometric analysis of the western blots.

Article Snippet: Human LO2 hepatocytes (Procell Biotechnology, China; catalog CM‐0111) were cultured in complete growth medium supplemented with 10% fetal bovine serum (FBS; Biosharp, China, catalog BL201A) and 1% penicillin‐streptomycin (Biosharp, China, catalogBL505A).

Techniques: Activation Assay, Control, Western Blot

Analysis of the expression of POC1A in various classifications of HCC patients, as well as in HCC and liver cancer cell lines. (A) Comparison of POC1A between cancer tissue samples and normal tissue samples. (B) Comparison of the expression of POC1A in different genders. (C) Comparison of the expression of POC1A in different age groups. (D) The expression levels of POC1A were all higher in the Caucasian, African-American, and Asian HCC patients than the normal patients. The expression of POC1A was significantly higher in LIHC tissue samples from Asian patients than LIHC tissue samples from Caucasian patients. (E) The expression of POC1A in individual cancer stages. (F) The expression of POC1A in different transistor grades. (G) The expression of POC1A in tumor (T) stage. (H) The expression of POC1A in node (N) stage. (I) The expression of POC1A in metastasis (M) stage. (J) Analysis of POC1A expression in normal liver tissue and cancer tissue samples from patients with hepatocellular carcinoma using immunohistochemical methods in the Human Protein Atlas database. Liver sample: https://www.proteinatlas.org/ENSG00000164087-POC1A/tissue/liver#img , hepatocellular samples: https://www.proteinatlas.org/ENSG00000164087-POC1A/pathology/liver+cancer#img . Scale bar: 100 µm. (K) Analysis of POC1A mRNA expression in LO2 and HepG2 cell lines by qPCR assay. *, P<0.05; **, P<0.01; -: no significance. TCGA, The Cancer Genome Atlas; HCC, hepatocellular carcinoma; LIHC, liver hepatocellular carcinoma; mRNA, messenger RNA; qPCR, quantitative polymerase chain reaction; POC1A , POC1 centriolar protein A.

Journal: Translational Cancer Research

Article Title: Analysis of the role of POC1A in the development and progression of hepatocellular carcinoma

doi: 10.21037/tcr-23-2398

Figure Lengend Snippet: Analysis of the expression of POC1A in various classifications of HCC patients, as well as in HCC and liver cancer cell lines. (A) Comparison of POC1A between cancer tissue samples and normal tissue samples. (B) Comparison of the expression of POC1A in different genders. (C) Comparison of the expression of POC1A in different age groups. (D) The expression levels of POC1A were all higher in the Caucasian, African-American, and Asian HCC patients than the normal patients. The expression of POC1A was significantly higher in LIHC tissue samples from Asian patients than LIHC tissue samples from Caucasian patients. (E) The expression of POC1A in individual cancer stages. (F) The expression of POC1A in different transistor grades. (G) The expression of POC1A in tumor (T) stage. (H) The expression of POC1A in node (N) stage. (I) The expression of POC1A in metastasis (M) stage. (J) Analysis of POC1A expression in normal liver tissue and cancer tissue samples from patients with hepatocellular carcinoma using immunohistochemical methods in the Human Protein Atlas database. Liver sample: https://www.proteinatlas.org/ENSG00000164087-POC1A/tissue/liver#img , hepatocellular samples: https://www.proteinatlas.org/ENSG00000164087-POC1A/pathology/liver+cancer#img . Scale bar: 100 µm. (K) Analysis of POC1A mRNA expression in LO2 and HepG2 cell lines by qPCR assay. *, P<0.05; **, P<0.01; -: no significance. TCGA, The Cancer Genome Atlas; HCC, hepatocellular carcinoma; LIHC, liver hepatocellular carcinoma; mRNA, messenger RNA; qPCR, quantitative polymerase chain reaction; POC1A , POC1 centriolar protein A.

Article Snippet: The human normal hepatocyte cell line LO2 (Servicebio Technology Co., Ltd., Wuhan, China) was cultured in Roswell Park Memorial Institute 1640 medium, and the hepatoma cell line HepG2 (Procell Life Science & Technology Co., Ltd., Wuhan, China) was cultured in Dulbecco’s Modified Eagle Medium (Hyclone, Thermo Fisher Scientific Inc., Waltham, MA), supplemented with 10% fetal bovine serum and antibiotics (10,000 U/mL penicillin and 10 mg/mL streptomycin) (Procell Life Science & Technology Co., Ltd.).

Techniques: Expressing, Comparison, Immunohistochemical staining, Real-time Polymerase Chain Reaction

Ferroptosis inhibitor attenuated ferroptosis-related death in LO2 cells under PA treatment. (a) Representative Oil Red O staining of the LO2 cells cultured in 300 μ M PA for 24 h; scale bar: 100 μ m. (b) The quantitative analysis of Oil Red O–stained cells. (c) The viability of LO2 cells treated with PA or PA and Fer-1 was assessed. The cells were treated with PA (300 μ M) or PA (300 μ M) and Fer-1 (60 μ M) for 24 h, and then the viability of cells in each group was measured by the CCK-8 assay. (d) The level of the LDH released in LO2 cells treated with PA or PA and Fer-1 was measured using the LDH cytotoxicity assay kit. (e, f) The LO2 cells were stained with the LPO-specific dye BODIPY 581/591 C11, and LPO was detected by flow cytometry after the LO2 cells were treated with PA or PA and Fer-1. (g, h) LO2 cells were treated with PA or PA and Fer-1, stained with Annexin V-FITC and PI, and then cells that underwent apoptosis were quantified by flow cytometry; ⁣ ∗ p < 0.05, ⁣ ∗∗ p < 0.01, and ⁣ ∗∗∗ p < 0.001 between the indicated groups.

Journal: Journal of Diabetes Research

Article Title: Autophagy Regulates Ferroptosis-Mediated Diabetic Liver Injury by Modulating the Degradation of ACSL4

doi: 10.1155/jdr/7146054

Figure Lengend Snippet: Ferroptosis inhibitor attenuated ferroptosis-related death in LO2 cells under PA treatment. (a) Representative Oil Red O staining of the LO2 cells cultured in 300 μ M PA for 24 h; scale bar: 100 μ m. (b) The quantitative analysis of Oil Red O–stained cells. (c) The viability of LO2 cells treated with PA or PA and Fer-1 was assessed. The cells were treated with PA (300 μ M) or PA (300 μ M) and Fer-1 (60 μ M) for 24 h, and then the viability of cells in each group was measured by the CCK-8 assay. (d) The level of the LDH released in LO2 cells treated with PA or PA and Fer-1 was measured using the LDH cytotoxicity assay kit. (e, f) The LO2 cells were stained with the LPO-specific dye BODIPY 581/591 C11, and LPO was detected by flow cytometry after the LO2 cells were treated with PA or PA and Fer-1. (g, h) LO2 cells were treated with PA or PA and Fer-1, stained with Annexin V-FITC and PI, and then cells that underwent apoptosis were quantified by flow cytometry; ⁣ ∗ p < 0.05, ⁣ ∗∗ p < 0.01, and ⁣ ∗∗∗ p < 0.001 between the indicated groups.

Article Snippet: Human hepatocyte LO2 cells were obtained from the China Center for Type Culture Collection (CCTCC, Wuhan, China) and cultured in Dulbecco's modified Eagle's medium (Gibco, United States) supplemented with 10% fetal bovine serum and 100 U/mL penicillin and streptomycin at 5% CO 2 .

Techniques: Staining, Cell Culture, CCK-8 Assay, LDH Cytotoxicity Assay, Flow Cytometry

ACSL4 increased under PA treatment and was degraded through the autophagy-lysosomal pathway. (a) RT-qPCR analysis of the expression of ACSL4 mRNA in the LO2 cells treated with PA or PA and Fer-1. (b, c) Representative Western blots and quantitative densitometry analysis of ACSL4 protein expression in LO2 cells treated with PA or PA and Fer-1. (d, e) Protein stability of ACSL4 in LO2 cells cultured with PA, following a time course treatment with 100 μ g/mL CHX. (f, g) LO2 cells were treated with PA with or without MG132 (20 μ M) or Baf A1 (20 nM) for 8 h. Representative Western blots and quantitative densitometry analysis of the expression of the ACSL4 protein in LO2 cells. All data are presented as the mean ± Std Dev of at least three independent experiments; ⁣ ∗ p < 0.05 between the indicated groups.

Journal: Journal of Diabetes Research

Article Title: Autophagy Regulates Ferroptosis-Mediated Diabetic Liver Injury by Modulating the Degradation of ACSL4

doi: 10.1155/jdr/7146054

Figure Lengend Snippet: ACSL4 increased under PA treatment and was degraded through the autophagy-lysosomal pathway. (a) RT-qPCR analysis of the expression of ACSL4 mRNA in the LO2 cells treated with PA or PA and Fer-1. (b, c) Representative Western blots and quantitative densitometry analysis of ACSL4 protein expression in LO2 cells treated with PA or PA and Fer-1. (d, e) Protein stability of ACSL4 in LO2 cells cultured with PA, following a time course treatment with 100 μ g/mL CHX. (f, g) LO2 cells were treated with PA with or without MG132 (20 μ M) or Baf A1 (20 nM) for 8 h. Representative Western blots and quantitative densitometry analysis of the expression of the ACSL4 protein in LO2 cells. All data are presented as the mean ± Std Dev of at least three independent experiments; ⁣ ∗ p < 0.05 between the indicated groups.

Article Snippet: Human hepatocyte LO2 cells were obtained from the China Center for Type Culture Collection (CCTCC, Wuhan, China) and cultured in Dulbecco's modified Eagle's medium (Gibco, United States) supplemented with 10% fetal bovine serum and 100 U/mL penicillin and streptomycin at 5% CO 2 .

Techniques: Quantitative RT-PCR, Expressing, Western Blot, Cell Culture

Downregulation of ACSL4 reversed PA-induced ferroptosis in LO2 cells. (a) qPCR analysis of ACSL4 mRNA expression in PA300+siNC or PA300 + siACSL4 LO2 cells. (b) Immunoblotting analysis of ACSL4 protein expression in PA300+siNC or PA300+siACSL4 LO2 cells. (c) Cell viability of PA-stimulated LO2 cells transfected with control and siACSL4 knockdown RNA. (d) Rate of LPO of PA-stimulated LO2 cells transfected with control and siACSL4 knockdown RNA. Bars represent the mean ± Std Dev; ⁣ ∗∗ p < 0.01 between the indicated groups.

Journal: Journal of Diabetes Research

Article Title: Autophagy Regulates Ferroptosis-Mediated Diabetic Liver Injury by Modulating the Degradation of ACSL4

doi: 10.1155/jdr/7146054

Figure Lengend Snippet: Downregulation of ACSL4 reversed PA-induced ferroptosis in LO2 cells. (a) qPCR analysis of ACSL4 mRNA expression in PA300+siNC or PA300 + siACSL4 LO2 cells. (b) Immunoblotting analysis of ACSL4 protein expression in PA300+siNC or PA300+siACSL4 LO2 cells. (c) Cell viability of PA-stimulated LO2 cells transfected with control and siACSL4 knockdown RNA. (d) Rate of LPO of PA-stimulated LO2 cells transfected with control and siACSL4 knockdown RNA. Bars represent the mean ± Std Dev; ⁣ ∗∗ p < 0.01 between the indicated groups.

Article Snippet: Human hepatocyte LO2 cells were obtained from the China Center for Type Culture Collection (CCTCC, Wuhan, China) and cultured in Dulbecco's modified Eagle's medium (Gibco, United States) supplemented with 10% fetal bovine serum and 100 U/mL penicillin and streptomycin at 5% CO 2 .

Techniques: Expressing, Western Blot, Transfection, Control, Knockdown

Inhibition of autophagic flux in PA-treated LO2 cells. (a, b) Representative Western blots and quantitative densitometry analysis of the expression of LC3-II, Beclin1, and p62 proteins in the LO2 cells exposed to PA for 24 h. (c, d) The LO2 cells were treated with PA for 24 h in the presence or absence of 20 nM Baf A1 during the last 2 h of coculture. Representative Western blots and quantitative densitometry analysis of the expression of the LC3-II protein in LO2 cells. (e) Representative images of LO2 cells infected with mRFP-GFP-LC3 and exposed to PA; Green: GFP puncta; Red: mRFP puncta. (f) GFP dots and mRFP dots were counted in each cell. (g) Semiquantitative analysis of autophagosomes (yellow puncta in merged images) and autolysosomes (red puncta in merged images). All data are presented as the mean ± Std Dev of at least three separate experiments; ns: nonsignificant; ⁣ ∗ p < 0.05, ⁣ ∗∗ p < 0.01, and ⁣ ∗∗∗ p < 0.001 between the indicated groups.

Journal: Journal of Diabetes Research

Article Title: Autophagy Regulates Ferroptosis-Mediated Diabetic Liver Injury by Modulating the Degradation of ACSL4

doi: 10.1155/jdr/7146054

Figure Lengend Snippet: Inhibition of autophagic flux in PA-treated LO2 cells. (a, b) Representative Western blots and quantitative densitometry analysis of the expression of LC3-II, Beclin1, and p62 proteins in the LO2 cells exposed to PA for 24 h. (c, d) The LO2 cells were treated with PA for 24 h in the presence or absence of 20 nM Baf A1 during the last 2 h of coculture. Representative Western blots and quantitative densitometry analysis of the expression of the LC3-II protein in LO2 cells. (e) Representative images of LO2 cells infected with mRFP-GFP-LC3 and exposed to PA; Green: GFP puncta; Red: mRFP puncta. (f) GFP dots and mRFP dots were counted in each cell. (g) Semiquantitative analysis of autophagosomes (yellow puncta in merged images) and autolysosomes (red puncta in merged images). All data are presented as the mean ± Std Dev of at least three separate experiments; ns: nonsignificant; ⁣ ∗ p < 0.05, ⁣ ∗∗ p < 0.01, and ⁣ ∗∗∗ p < 0.001 between the indicated groups.

Article Snippet: Human hepatocyte LO2 cells were obtained from the China Center for Type Culture Collection (CCTCC, Wuhan, China) and cultured in Dulbecco's modified Eagle's medium (Gibco, United States) supplemented with 10% fetal bovine serum and 100 U/mL penicillin and streptomycin at 5% CO 2 .

Techniques: Inhibition, Western Blot, Expressing, Infection

Autophagy may be involved in ferroptosis by regulating the expression of ACSL4. (a) CCK-8 assay was performed to determine the viability of LO2 cells treated with various concentrations of 3-MA for 24 h. (b) The level of the LDH released in LO2 cells treated with various concentrations of 3-MA for 24 h was measured using the LDH cytotoxicity assay kit. (c, d) LO2 cells were treated with 5 mM 3-MA for 24 h and stained with the LPO-specific dye BODIPY 581/591 C11, and LPO was detected by flow cytometry. (e, f) LO2 cells were treated with 5 mM 3-MA for 24 h and stained with Annexin V-FITC and PI, and then the cells that underwent apoptosis were quantified by flow cytometry. (g, h) Representative Western blots and quantitative densitometry analysis of the expression of the ACSL4 and LC3-II proteins in LO2 cells cultured with 3-MA for 24 h. (i, j) LO2 cells were treated with BSA, BSA+Rap (50 nM), PA (300 μ M), or PA (300 μ M)+Rap (50 nM) for 24 h. Representative Western blots and quantitative densitometry analysis of the expression of ACSL4 and LC3 proteins in LO2 cells. All data are presented as the mean ± Std Dev of at least three separate experiments; ns: nonsignificant; ⁣ ∗ p < 0.05 and ⁣ ∗∗ p < 0.01 between the indicated groups.

Journal: Journal of Diabetes Research

Article Title: Autophagy Regulates Ferroptosis-Mediated Diabetic Liver Injury by Modulating the Degradation of ACSL4

doi: 10.1155/jdr/7146054

Figure Lengend Snippet: Autophagy may be involved in ferroptosis by regulating the expression of ACSL4. (a) CCK-8 assay was performed to determine the viability of LO2 cells treated with various concentrations of 3-MA for 24 h. (b) The level of the LDH released in LO2 cells treated with various concentrations of 3-MA for 24 h was measured using the LDH cytotoxicity assay kit. (c, d) LO2 cells were treated with 5 mM 3-MA for 24 h and stained with the LPO-specific dye BODIPY 581/591 C11, and LPO was detected by flow cytometry. (e, f) LO2 cells were treated with 5 mM 3-MA for 24 h and stained with Annexin V-FITC and PI, and then the cells that underwent apoptosis were quantified by flow cytometry. (g, h) Representative Western blots and quantitative densitometry analysis of the expression of the ACSL4 and LC3-II proteins in LO2 cells cultured with 3-MA for 24 h. (i, j) LO2 cells were treated with BSA, BSA+Rap (50 nM), PA (300 μ M), or PA (300 μ M)+Rap (50 nM) for 24 h. Representative Western blots and quantitative densitometry analysis of the expression of ACSL4 and LC3 proteins in LO2 cells. All data are presented as the mean ± Std Dev of at least three separate experiments; ns: nonsignificant; ⁣ ∗ p < 0.05 and ⁣ ∗∗ p < 0.01 between the indicated groups.

Article Snippet: Human hepatocyte LO2 cells were obtained from the China Center for Type Culture Collection (CCTCC, Wuhan, China) and cultured in Dulbecco's modified Eagle's medium (Gibco, United States) supplemented with 10% fetal bovine serum and 100 U/mL penicillin and streptomycin at 5% CO 2 .

Techniques: Expressing, CCK-8 Assay, LDH Cytotoxicity Assay, Staining, Flow Cytometry, Western Blot, Cell Culture